Presentations

ISCHEMIA Presentations at National and International Meetings

  • Impact of Completeness of Revascularization on Clinical Outcomes in Patients With Stable Ischemic Heart Disease Treated With an Invasive Versus Conservative Strategy. (Presented by Dr. Gregg W. Stone at ACC.21 May 2021) (LBCT) Link
  • Dialysis Initiation in Patients with Stable Ischemic Heart Disease and Severe Chronic Kidney Disease in the ISCHEMIA-CKD Trial. (Presented by Dr. Carlo Briguori) (Moderated Poster) Link
  • Association of BMI with Clinical Outcomes in Patients with Coronary Disease and Advanced Chronic Kidney Disease: Insights for the ISCHEMIA-CKD Trial. (Poster presented by Dr. Evgeny Kretov at ACC.21 May 2021) Link
  • Global Longitudinal Strain at Rest is Not Predictive of Subsequent Inducible Ischemia Among Patients with Non-Obstructive Coronary Artery Disease in the CIAO-ISCHEMIA Study. (Poster Contribution resented by Dr. Esther Davis at ACC.21 May 2021) Link
  • Management and Outcomes of Patients with Diabetes Mellitus (DM) and Stable Ischemic Heart Disease (SIHD): Pooled Data from the ISCHEMIA and ISCHEMIA-CKD Trials. (Poster presented by Dr. Jonathan Newman at ACC.21 May 2021) Link
  • Anatomy Versus Ischemia in the ISCHEMIA-CKD Trial: Does Either Predict Outcome? (Poster presented by Dr. Kevin Bainey at ACC.21 May 2021) Link
  • Myocardial Infarction Rates by Definition, Type, and Treatment in the ISCHEMIA-CKD Trial (Moderated Poster presented by Dr. Bernard Chaitman at ACC.21 May 2021)  Link
  • Clinical And Quality Of Life Outcomes With Chronic Total Occlusion In ISCHEMIA: ISCHEMIA CTO Substudy. (Presented by Dr. Sripal Bangalore at AHA November 2020) (LBCT) Link
  • Causes Of Cardiovascular And Non-cardiovascular Mortality In The ISCHEMIA Trial (Presented by Dr. Mandeep Sidhu at AHA November 2020) Link
  • Optimal medical therapy in the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)-Chronic Kidney Disease (CKD): A comparison of patients on and not on dialysis at baseline. (Presented by Dr. Roy Matthew at ASN October 2020) Link
  • Initial Invasive versus Conservative Management for Stable Ischemic Heart Disease with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.(Presented by R.D. Lopes at ESC Congress August 2020) Link
  • Outcomes with Intermediate Left Main Disease on Coronary CT Angiography in the ISCHEMIA trial. (Presented by S. Bangalore at SCAI May 2020) Link
  • Variation in Myocardial Infarction Rates By Type And Definition In the ISCHEMIA Trial. (Presented by B. Chaitman at ACC March 2020) Link
  • Predictions of Left Main Disease Using Clinical and Stress Test Parameters. (Presented by R. Senior at ACC 2020) Link
  • Relationships Of Ischemia Severity And Coronary Artery Disease Extent With Clinical Outcomes In The Ischemia Trial. (Presented by D. Maron at ACC March 2020) Link
  • Coronary Anatomy, Ischemia and Angina: Associations at Baseline in the ISCHEMIA trial. (Presented by H. Reynolds at ACC March 2020) Link
  • Sex Differences in Stress Test and CCTA Findings and Symptoms in the Randomized Ischemia Trial. (Presented by H. Reynolds at ACC March 2020) Link
  • Clinical And Quality Of Life Outcomes With Invasive Versus Conservative Strategy In Patients With Stable Ischemic Heart Disease Across The Spectrum Of Baseline Kidney Function: Insights From The ISCHEMIA And ISCHEMIA-CKD Trials. (Presented by S. Bangalore at ACC March 2020) Link
  • Natural History Of Symptoms And Stress Echo Findings In Patients With Moderate Or Severe Ischemia And No Obstructive CAD (INOCA): The NHLBI-funded CIAO Ancillary Study To The ISCHEMIA Trial. (Presented by H. Reynolds at ACC March 2020) Link